Cost-related delayed or forgone care was associated with 78% higher odds of an ED visit among Latino adults, indicating ...
The "Checkpoint Inhibitor Refractory Cancer Drugs Market -- Growth, Share, Opportunities & Competitive Analysis, 2025 -- 2032" report has been added to the Credence Research Inc. offering. The global ...
Strengthened Executive Leadership. In February 2026, Foghorn appointed Ryan Maynard as Chief Financial Officer. Mr. Maynard joins Foghorn with over 25 years of executive experience driving financial ...
BBO-11818 is a selective, orally bioavailable non-covalent inhibitor that targets KRAS in both the ON and OFF states, has high selectivity over ...
(Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced the first patient dosed in ...
Jay Bregman, CEO and co-founder of Andel discusses how FDA’s planned action against non-FDA-approved GLP-1 products could reshape competition in obesity and diabetes care. In a conversation with ...
Findings from a study analyzing 36 high-intent business search terms identified the industries facing the highest barriers to organic search visibility on Google in 2026. The study from Social Market ...
This study was supported by a British Academy/Leverhulme Small Grant (Reference no.: SRG23\231049). The author declares no other relevant affiliations or financial interests. Andrea Révész and Andreas ...
Family business leaders often feel pressure to “professionalize” their businesses, adopting the structures and behaviors of non-family corporations. However, when they push this too far, they can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results